178 related articles for article (PubMed ID: 16164754)
21. [A study of cervical cancer screening algorithms].
Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
[TBL] [Abstract][Full Text] [Related]
22. Performance of self-sampled HPV test in comparison with liquid based cytology.
Igidbashian S; Boveri S; Radice D; Casadio C; Spolti N; Sandri MT; Sideri M
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():72-6. PubMed ID: 24768230
[TBL] [Abstract][Full Text] [Related]
23. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.
Kitchener HC; Almonte M; Thomson C; Wheeler P; Sargent A; Stoykova B; Gilham C; Baysson H; Roberts C; Dowie R; Desai M; Mather J; Bailey A; Turner A; Moss S; Peto J
Lancet Oncol; 2009 Jul; 10(7):672-82. PubMed ID: 19540162
[TBL] [Abstract][Full Text] [Related]
24. The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China.
Zhang SK; Guo Z; Wang P; Kang LN; Jia MM; Wu ZN; Chen Q; Cao XQ; Zhao DM; Guo PP; Sun XB; Zhang JG; Qiao YL
Front Oncol; 2020; 10():533253. PubMed ID: 33123463
[TBL] [Abstract][Full Text] [Related]
25. Comparison of conventional Pap smear and liquid-based cytology: A study of cervical cancer screening at a tertiary care center in Bihar.
Pankaj S; Nazneen S; Kumari S; Kumari A; Kumari A; Kumari J; Choudhary V; Kumar S
Indian J Cancer; 2018; 55(1):80-83. PubMed ID: 30147099
[TBL] [Abstract][Full Text] [Related]
26. Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination.
Grimes DR; Corry EMA; Malagón T; O'Riain C; Franco EL; Brennan DJ
JAMA Netw Open; 2021 Jun; 4(6):e2115321. PubMed ID: 34190993
[TBL] [Abstract][Full Text] [Related]
27. Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity.
Darlin L; Borgfeldt C; Forslund O; Hénic E; Dillner J; Kannisto P
J Clin Virol; 2013 Jan; 56(1):52-6. PubMed ID: 23017435
[TBL] [Abstract][Full Text] [Related]
28. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.
Strander B; Andersson-Ellström A; Milsom I; Rådberg T; Ryd W
Cancer; 2007 Oct; 111(5):285-91. PubMed ID: 17724676
[TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of p16
Rezhake R; Wang Y; Chen F; Hu SY; Zhang X; Cao J; Qiao YL; Zhao FH; Arbyn M
Cancer Cytopathol; 2021 Sep; 129(9):679-692. PubMed ID: 33826790
[TBL] [Abstract][Full Text] [Related]
30. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.
Kitchener HC; Almonte M; Gilham C; Dowie R; Stoykova B; Sargent A; Roberts C; Desai M; Peto J;
Health Technol Assess; 2009 Nov; 13(51):1-150, iii-iv. PubMed ID: 19891902
[TBL] [Abstract][Full Text] [Related]
31. A randomised comparison of SurePath liquid-based cytology and conventional smear cytology in a colposcopy clinic setting.
Sykes PH; Harker DY; Miller A; Whitehead M; Neal H; Wells JE; Peddie D
BJOG; 2008 Oct; 115(11):1375-81. PubMed ID: 18823488
[TBL] [Abstract][Full Text] [Related]
32. High-risk HPV testing vs liquid-based cytology for cervical cancer screening among 25- to 30-year-old women: A historical cohort study.
Feldstein O; Gali-Zamir H; Schejter E; Feinberg T; Yehuda-Shnaidman E; Bornstein J; Levy T
Acta Obstet Gynecol Scand; 2023 Feb; 102(2):226-233. PubMed ID: 36478537
[TBL] [Abstract][Full Text] [Related]
33. Detection of HIV mRNA in routine liquid-based cytology specimens of HIV-infected women.
Brito MJ; Quintas A; Sequeira P; Alves AT; Martins C; Félix A
Cytopathology; 2021 Sep; 32(5):640-645. PubMed ID: 33914385
[TBL] [Abstract][Full Text] [Related]
34. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
[TBL] [Abstract][Full Text] [Related]
35. Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results.
Mo LZ; Monnier-Benoit S; Kantelip B; Petitjean A; Riethmuller D; Prétet JL; Mougin C
J Clin Virol; 2008 Feb; 41(2):104-10. PubMed ID: 18036888
[TBL] [Abstract][Full Text] [Related]
36. Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
Lindroth Y; Pedersen L; Alssamaray J; Berglund T; Sundqvist A; Borgfeldt C; Forslund O
Acta Obstet Gynecol Scand; 2024 Feb; 103(2):378-386. PubMed ID: 37964497
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Kreimer AR; Guido RS; Solomon D; Schiffman M; Wacholder S; Jeronimo J; Wheeler CM; Castle PE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):908-14. PubMed ID: 16702369
[TBL] [Abstract][Full Text] [Related]
38. Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa.
Dreyer G; Maske C; Stander M
PLoS One; 2019; 14(9):e0221495. PubMed ID: 31509545
[TBL] [Abstract][Full Text] [Related]
39. Liquid-Based Cervical Cytology: Monitoring the Laboratory Quality Indicators.
Nayak SS; Dutta A; Khedkar R; Roy S
J Cytol; 2024; 41(1):1-7. PubMed ID: 38282808
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the application values of different combination schemes of liquid-based cytology and high-risk human papilloma virus test in the screening of high-grade cervical lesions.
Wang J
Braz J Med Biol Res; 2018 Nov; 52(1):e7517. PubMed ID: 30484489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
